Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Alzheimer’s Solution Shows Promise after Big Pharma’s Cure Fails

Two major pharmaceutical companies developing advanced-stage R&D on Alzheimer’s disease have just pulled the plug ontheir research. The reason why their approach to Alzheimer’s, Aducanumab, failed is because it didn’t account f...
Stockhouse Editorial | March 28, 2019 |

Stocks Seem Unfazed By the Stimulus Promise, So Far

After Monday’s plunge, stocks staged a rebound on Trump’s stimulus promises. While the bulls closed higher than the market opened on Monday, was it a resounding show of their strength? Let’s jump right into the daily chart to...
Monica Kingsley | March 11, 2020 |

XPhyto: Is Mescaline the Next Big Mood-Modifying Medicine?

It has the potential to be the next frontier in the psychedelics renaissance, and it represents an unprecedented opportunity to innovate a notable advancement in mental health therapy. In anecdotal studies, mescaline has shown promise in treating depression, anxiety, PTSD,...
Marc Davis | April 6, 2021 |

Bids becoming more aggressive for gold/base metals explorer

Edited by Sean Mason This is just a brief, possible heads up, on another one of the companies on our Vulture list, Paragon Minerals ( TSX: V.PGR , Stock Forum ) , which is currently drilling their South Tally Pond zinc-lead-copper-silver-gold volcanogenic massive s...
Gene Arensberg | October 28, 2012 |

April 21st 2020, Crypto Chartbook: Uncertainty – opportunity in disguise

Uncertainty – opportunity in disguise We have just entered into a future with a higher degree of uncertainty. Times of more rapid change promise innovation, a higher degree of risk taking, in short evolution on steroids awaits. History shows that times like these spell op...
Korbinian Koller | April 22, 2020 |

Riverside Resources – Strategic, Accretive, and Blue Sky

Riverside Resources (TSX.V: RRI | OTCQB: RVSDF ) In this exclusive interview, Dr. John-Mark Staude of Riverside Resources sits down with Maurice Jackson of Proven and Probable to discuss the strategic acquisition the company has made to expand the property bank footp...
Maurice Jackson | September 25, 2019 |

A New Frontier in Psychedelic Therapeutics

Cybin X Kernel "A New Frontier in Psychedelic Therapeutics" About the partnership: Cybin Corporation ( N.CYBN , Forum ) will leverage Kernel’s Flow to quantify brain activity during psychedelic experiences in re...
Featured Submission | January 11, 2021 |

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...
Marc Davis | June 25, 2021 |

Gold and Gold Stocks Stop Short of Bull Market, Again

The recent rally showed quite a bit of promise. Gold stocks surged past their long-term moving averages while breadth indicators surpassed all prior bear market peaks (excluding 2016). 71% of the HUI and 81% of GDXJ closed above the 200-day moving average. GDX and GDXJ...
Jordan Roy-Byrne, CMT | March 5, 2019 |

The promise of AI

In ‘The Terminator’ series of action films starring Arnold Schwarzenegger, a cybernetic organism (cyborg) is programmed from the future to go back in time and kill the mother of the scientist who leads the fight against Skynet, an artificial intelligence syst...
Richard (Rick) Mills | November 22, 2019 |
1 2 3 4 5 6 7 8 9 10 ...